Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis.
about
Disruption of a Regulatory Network Consisting of Neutrophils and Platelets Fosters Persisting Inflammation in Rheumatic DiseasesDo neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases?Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with DysregulationIntercellular Interactions as Regulators of NETosisInhibition of NET Release Fails to Reduce Adipose Tissue Inflammation in MiceLactoferrin Suppresses Neutrophil Extracellular Traps Release in InflammationMénage-à-Trois: The Ratio of Bicarbonate to CO2 and the pH Regulate the Capacity of Neutrophils to Form NETsExperimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps.Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation.Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal.The role of neutrophils and NETosis in autoimmune and renal diseases.Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.Chemical biology of protein arginine modifications in epigenetic regulationPlatelet-neutrophil interactions under thromboinflammatory conditionsA novel image-based quantitative method for the characterization of NETosis.Protein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor design.At the Bench: Neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases.Chemical Proteomic Platform To Identify Citrullinated ProteinsNeutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease.Extracellular traps and macrophages: new roles for the versatile phagocyte.Cholesterol in platelet biogenesis and activation.Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis.Neutrophils in animal models of autoimmune diseaseAbrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses.Interleukin 6 regulates psoriasiform inflammation-associated thrombosis.NETosis in Alzheimer's Disease.A novel role for protein arginine deiminase 4 in pluripotency: the emerging role of citrullinated histone H1 in cellular programming.Neutrophil Extracellular Traps and Endothelial Dysfunction in Atherosclerosis and Thrombosis.Role of neutrophils in atherogenesis: an update.PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis.Review: Neutrophils as Invigorated Targets in Rheumatic DiseasesDesign, synthesis, and biological evaluation of tetrazole analogs of Cl-amidine as protein arginine deiminase inhibitors.New Aspects of the Biology of Neutrophil Extracellular Traps.Neutrophil-mediated vascular barrier injury: Role of neutrophil extracellular traps.An emerging role for neutrophil extracellular traps in noninfectious disease.Neutrophils as protagonists and targets in chronic inflammation.Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release?Mechanisms of erosion of atherosclerotic plaques.The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris.
P2860
Q26744644-0D394F32-E0B4-4DC7-BCEB-497C23543478Q26771128-365F333F-E543-4BCA-84E0-657EEFFE3A0CQ27001595-BA3ACE8F-0450-4C4F-A17F-901E9C21C44DQ28078773-9B24985A-34D4-4692-9E29-69FA242E9066Q28554463-C9553026-FEDD-4669-975F-5100757CDC18Q28828347-9CD6AD66-C534-4AD6-8D1C-D1E1F087E2ACQ30831357-C7F52BE6-29C1-46C3-8D1A-1A874AB77804Q33703190-DCCE1604-8C8A-47B1-B604-79CED679FEDFQ33811944-6E979C17-7B19-4FD7-ACB8-2DE374B15EB7Q33816141-C28E2307-6773-4469-A27F-49ED8BA0CB3BQ33904653-45DD9983-F038-48F4-856B-72B2CE39918FQ34084599-B63874D1-E16E-4499-A501-E529D5B559BEQ35060808-8D0E0018-C3DA-4B38-B06C-83D4C0F810BCQ35722457-2E55A61F-2CFE-4AA6-BA1A-9A40535470A4Q35779411-72765059-1111-452A-A44A-6ADF07CF7606Q35908463-B2136204-9C10-4551-9A4D-0175E0EBF505Q36057948-D109BA9C-A692-44A4-8D62-839E8AD40308Q36477921-CE0BA829-5951-4B67-A29E-9964159B30C3Q36509456-ECDE0D37-3677-4021-99E3-564FC1A18BFFQ36547411-B8DD8073-CCDD-42FD-B72A-2FB0AB15447BQ36607908-698E2D03-0209-4252-BA8A-27A88FB93717Q36825794-5CF304B2-ED83-4A9D-A40B-8C3A39AE6426Q36862166-ECACCBA8-D456-4B45-A2DA-5A55A5B080C1Q36902110-7C905661-07A0-4D73-84CC-1AC9A661E55AQ36925292-385B026E-87C6-4511-A094-F473CEFB6848Q37469175-44E65135-BFD6-4BE2-9E2C-5BD7D8FA6C14Q37675611-B26BC482-4BB9-44DA-AAD0-818D8EEE21BAQ38449033-8B1FD5F4-8F1F-425D-B8D5-694345E94695Q38616682-E97786F8-7C92-4002-A4A8-1AB2DB7464E8Q38634721-1C03D52E-60B0-4240-815A-E9EB48EB99E2Q38747640-C1AF546E-B98A-4934-8806-8B61CD3E2B46Q38829722-41A3228B-0F22-407A-89A5-63FBBEA039ABQ38923181-C7555799-67ED-4185-A7CE-4BB3CEA0956AQ38964365-8ED4E542-8542-43E0-BA19-7C431CC953A4Q39102339-618DFF33-BED0-4944-904A-A8F52524BB4BQ39166302-341291EE-D476-43FB-A3DA-3036FF61536AQ39175804-6A0EB790-3919-4A9C-9D7E-329950349C0FQ39354673-20F8291D-7D46-49D6-846C-7BF5A0A4C408Q39418237-F62855A7-F4FC-49C0-9D25-B2BAC195D9C7Q40248462-8D268196-4551-46D3-9CF1-F5DA27AF389E
P2860
Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Peptidylarginine deiminase inh ...... ine models of atherosclerosis.
@ast
Peptidylarginine deiminase inh ...... ine models of atherosclerosis.
@en
Peptidylarginine deiminase inh ...... ine models of atherosclerosis.
@en-gb
Peptidylarginine deiminase inh ...... ine models of atherosclerosis.
@nl
type
label
Peptidylarginine deiminase inh ...... ine models of atherosclerosis.
@ast
Peptidylarginine deiminase inh ...... ine models of atherosclerosis.
@en
Peptidylarginine deiminase inh ...... ine models of atherosclerosis.
@en-gb
Peptidylarginine deiminase inh ...... ine models of atherosclerosis.
@nl
prefLabel
Peptidylarginine deiminase inh ...... ine models of atherosclerosis.
@ast
Peptidylarginine deiminase inh ...... ine models of atherosclerosis.
@en
Peptidylarginine deiminase inh ...... ine models of atherosclerosis.
@en-gb
Peptidylarginine deiminase inh ...... ine models of atherosclerosis.
@nl
P2093
P2860
P1433
P1476
Peptidylarginine deiminase inh ...... ine models of atherosclerosis.
@en
P2093
Alexander A O'Dell
Daniel T Eitzman
Jason S Knight
Mariana J Kaplan
Paul R Thompson
Robert C Grenn
Srilakshmi Yalavarthi
Wenpu Zhao
P2860
P304
P356
10.1161/CIRCRESAHA.114.303312
P577
2014-01-14T00:00:00Z